MENU
PTGX
AS OF
Nov 13 closing price
Price
$83.24
Change
-$1.61 (-1.90%)
Capitalization
5.2B
124 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
PTGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Protagonist Therapeutics (PTGX) Ownership - Who owns Protagonist Therapeutics?

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
112
Web
https://www.protagonist-inc.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.2B
P/E Ratio
126.03
Total Cash
570.47M
Projected Growth
N/A
Total Debt
11.28M
Revenue
209.18M
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash/Share
9.13
Total Debt/Equity
N/A
Revenue/Share
3.26 USD as % of share price

Fundamentals

PTGX
Capitalization
5.2B
P/E Ratio
126.03
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash
570M
Total Cash/Share
9.13
Total Debt
11.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.26%
Revenue
209M
ROE
N/A
Book Value
668M
P/B Ratio
8.06
Cash Flow
N/A
Earnings
0.85
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
16.97
Current Revenue Per Employee
42661.54
Dividends Per Share - Security
N/A
EBITDA
26.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
7.81
Shares Held By Institutions
5.59B
Shares Outstanding - Current
62.5M
Total Liabilities
50M
Total Volume MTD
N/A
Value
-1
Gain YTD
115.648
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Choppy Market Trader for Beginners: Hi-tech Stocks (TA&FA)
60minChoppy Market Trader for Beginners: Hi-tech Stocks (TA&FA)
60min
Annualized Return+87%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
PTGX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PTGX showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for PTGX
A.I. Advisor
published General Information

General Information

a developer of disulfide-rich peptides

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
112
Web
https://www.protagonist-inc.com